Acadia Healthcare Company (ACHC) Stock Forecast, Price Target & Predictions
ACHC Stock Forecast
Acadia Healthcare Company stock forecast is as follows: an average price target of $82.33 (represents a 121.97% upside from ACHC’s last price of $37.09) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.
ACHC Price Target
The average price target for Acadia Healthcare Company (ACHC) is $82.33 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $100.00 to $70.00. This represents a potential 121.97% upside from ACHC's last price of $37.09.
ACHC Analyst Ratings
According to 9 Wall Street analysts, Acadia Healthcare Company's rating consensus is 'Buy'. The analyst rating breakdown for ACHC stock is 0 'Strong Buy' (0.00%), 6 'Buy' (66.67%), 3 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Acadia Healthcare Company Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 21, 2024 | Whit Mayo | Leerink Partners | $87.00 | $52.03 | 67.21% | 134.56% |
| Sep 27, 2024 | Andrew Mok | Barclays | $76.00 | $63.87 | 18.99% | 104.91% |
| Aug 01, 2024 | Andrew Mok | Barclays | $83.00 | $64.85 | 27.99% | 123.78% |
| May 22, 2024 | Frank Morgan | RBC Capital | $94.00 | $66.64 | 41.06% | 153.44% |
| May 03, 2024 | Ann Hynes | Mizuho Securities | $70.00 | $66.73 | 4.90% | 88.73% |
| Apr 25, 2024 | Pito Chickering | Deutsche Bank | $70.00 | $71.19 | -1.67% | 88.73% |
| Dec 12, 2022 | - | RBC Capital | $93.00 | $82.25 | 13.07% | 150.74% |
| Aug 26, 2022 | - | Leerink Partners | $103.00 | $85.23 | 20.85% | 177.70% |
| Aug 01, 2022 | - | RBC Capital | $94.00 | $82.91 | 13.38% | 153.44% |
| Aug 01, 2022 | - | Raymond James | $100.00 | $82.91 | 20.61% | 169.61% |
The latest Acadia Healthcare Company stock forecast, released on Oct 21, 2024 by Whit Mayo from Leerink Partners, set a price target of $87.00, which represents a 67.21% increase from the stock price at the time of the forecast ($52.03), and a 134.56% increase from ACHC last price ($37.09).
Acadia Healthcare Company Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 2 | 6 |
| Avg Price Target | $87.00 | $81.50 | $80.00 |
| Last Closing Price | $37.09 | $37.09 | $37.09 |
| Upside/Downside | 134.56% | 119.74% | 115.69% |
In the current month, the average price target of Acadia Healthcare Company stock is $87.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 134.56% increase as opposed to Acadia Healthcare Company's last price of $37.09. This month's average price target is up 6.75% compared to last quarter, and up 8.75% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 21, 2024 | Leerink Partners | Outperform | Outperform | Hold |
| Oct 11, 2024 | RBC Capital | Hold | Hold | Hold |
| Oct 11, 2024 | Raymond James | Underperform | Underperform | Hold |
| Oct 10, 2024 | KeyBanc | - | Sector Weight | Initialise |
| Sep 27, 2024 | Barclays | Overweight | Overweight | Hold |
| Sep 20, 2024 | RBC Capital | Hold | Hold | Hold |
| Sep 20, 2024 | Raymond James | Underperform | Underperform | Hold |
| Aug 19, 2024 | RBC Capital | Hold | Hold | Hold |
| Aug 02, 2024 | Raymond James | Underperform | Underperform | Hold |
| Aug 02, 2024 | RBC Capital | Buy | Buy | Hold |
Acadia Healthcare Company's last stock rating was published by Leerink Partners on Oct 21, 2024. The company gave ACHC a "Outperform" rating, the same as its previous rate.
Acadia Healthcare Company Financial Forecast
Acadia Healthcare Company Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $742.80M | $750.33M | $731.34M | $704.27M | $675.29M | $666.73M | $651.72M | $616.65M | $593.48M | $587.56M | $582.16M | $551.20M | $541.28M | $833.30M | $750.31M | $782.81M | $780.23M | $777.25M |
| Avg Forecast | $951.32M | $973.07M | $946.80M | $911.91M | $871.14M | $893.23M | $866.25M | $830.53M | $787.22M | $819.42M | $785.73M | $779.17M | $727.60M | $726.23M | $711.92M | $689.62M | $660.39M | $657.50M | $650.82M | $606.52M | $588.00M | $591.41M | $560.76M | $544.71M | $826.97M | $800.25M | $763.07M | $793.23M | $780.27M | $790.48M |
| High Forecast | $974.33M | $996.61M | $969.70M | $933.97M | $892.21M | $914.84M | $887.20M | $840.42M | $812.86M | $819.64M | $786.40M | $779.18M | $732.83M | $726.24M | $729.14M | $706.31M | $676.36M | $657.50M | $650.82M | $606.52M | $588.00M | $591.41M | $560.76M | $544.71M | $826.97M | $800.25M | $763.07M | $793.23M | $780.27M | $790.48M |
| Low Forecast | $935.42M | $956.81M | $930.98M | $896.67M | $856.58M | $878.30M | $851.77M | $822.66M | $773.47M | $819.20M | $785.05M | $779.15M | $723.49M | $726.23M | $700.02M | $678.10M | $649.35M | $657.50M | $650.82M | $606.52M | $588.00M | $591.41M | $560.76M | $544.71M | $826.97M | $800.25M | $763.07M | $793.23M | $780.27M | $790.48M |
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 9 | 4 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 9 | 8 | 7 | 6 | 5 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.03% | 1.03% | 1.02% | 1.02% | 1.01% | 1.00% | 1.02% | 1.01% | 0.99% | 1.04% | 1.01% | 0.65% | 1.04% | 0.98% | 0.99% | 1.00% | 0.98% |
Acadia Healthcare Company's average Quarter revenue forecast for Mar 24 based on 4 analysts is $779.17M, with a low forecast of $779.15M, and a high forecast of $779.18M. ACHC's average Quarter revenue forecast represents a 4.90% increase compared to the company's last Quarter revenue of $742.80M (Dec 23).
Acadia Healthcare Company EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 9 | 4 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 9 | 8 | 7 | 6 | 5 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $133.79M | $-235.45M | $148.10M | $137.21M | $137.62M | $144.68M | $155.35M | $124.03M | $143.75M | $127.05M | $106.18M | $69.84M | $-755.98M | $124.63M | $129.47M | $123.72M | $74.29M | $136.67M |
| Avg Forecast | $155.41M | $158.96M | $154.67M | $148.97M | $142.31M | $145.92M | $141.51M | $135.68M | $128.60M | $133.86M | $128.36M | $141.80M | $118.86M | $118.64M | $116.30M | $128.91M | $160.46M | $139.65M | $138.24M | $117.19M | $124.89M | $125.62M | $119.11M | $66.74M | $175.65M | $169.97M | $162.08M | $110.69M | $165.73M | $167.90M |
| High Forecast | $159.17M | $162.81M | $158.41M | $152.58M | $145.75M | $149.45M | $144.94M | $137.29M | $132.79M | $133.90M | $128.47M | $170.16M | $119.72M | $118.64M | $119.11M | $154.69M | $192.55M | $139.65M | $138.24M | $140.63M | $124.89M | $125.62M | $119.11M | $80.09M | $175.65M | $169.97M | $162.08M | $132.83M | $165.73M | $167.90M |
| Low Forecast | $152.81M | $156.31M | $152.09M | $146.48M | $139.93M | $143.48M | $139.15M | $134.39M | $126.36M | $133.83M | $128.25M | $113.44M | $118.19M | $118.64M | $114.36M | $103.13M | $128.36M | $139.65M | $138.24M | $93.75M | $124.89M | $125.62M | $119.11M | $53.39M | $175.65M | $169.97M | $162.08M | $88.56M | $165.73M | $167.90M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.13% | -1.98% | 1.27% | 1.06% | 0.86% | 1.04% | 1.12% | 1.06% | 1.15% | 1.01% | 0.89% | 1.05% | -4.30% | 0.73% | 0.80% | 1.12% | 0.45% | 0.81% |
4 analysts predict ACHC's average Quarter EBITDA for Mar 24 to be $141.80M, with a high of $170.16M and a low of $113.44M. This is 5.98% upper than Acadia Healthcare Company's previous annual EBITDA (Dec 23) of $133.79M.
Acadia Healthcare Company Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 9 | 4 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 9 | 8 | 7 | 6 | 5 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $57.73M | $-217.71M | $72.30M | $66.02M | $61.12M | $71.10M | $80.08M | $60.84M | $71.52M | $66.13M | $44.51M | $9.72M | $-783.67M | $37.00M | $41.08M | $33.46M | $-11.25M | $42.57M |
| Avg Forecast | $93.00M | $103.00M | $100.22M | $85.27M | $82.09M | $93.09M | $89.26M | $76.04M | $69.48M | $82.92M | $80.79M | $70.16M | $73.07M | $82.22M | $79.06M | $63.78M | $83.94M | $72.36M | $71.61M | $57.99M | $62.87M | $66.65M | $57.87M | $9.29M | $58.49M | $49.47M | $35.63M | $29.94M | $45.36M | $50.89M |
| High Forecast | $95.93M | $106.23M | $103.38M | $87.95M | $84.67M | $96.02M | $92.06M | $83.64M | $80.75M | $83.08M | $81.08M | $84.19M | $75.81M | $82.31M | $81.55M | $76.54M | $100.73M | $72.36M | $71.61M | $69.58M | $62.87M | $66.65M | $57.87M | $11.14M | $58.49M | $49.47M | $35.63M | $35.93M | $45.36M | $50.89M |
| Low Forecast | $90.98M | $100.76M | $98.05M | $83.42M | $80.31M | $91.07M | $87.32M | $71.29M | $64.79M | $82.75M | $80.50M | $56.13M | $70.33M | $82.13M | $77.35M | $51.03M | $67.15M | $72.36M | $71.61M | $46.39M | $62.87M | $66.65M | $57.87M | $7.43M | $58.49M | $49.47M | $35.63M | $23.95M | $45.36M | $50.89M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.79% | -2.65% | 0.91% | 1.03% | 0.73% | 0.98% | 1.12% | 1.05% | 1.14% | 0.99% | 0.77% | 1.05% | -13.40% | 0.75% | 1.15% | 1.12% | -0.25% | 0.84% |
Acadia Healthcare Company's average Quarter net income forecast for Mar 24 is $70.16M, with a range of $56.13M to $84.19M. ACHC's average Quarter net income forecast represents a 21.54% increase compared to the company's last Quarter net income of $57.73M (Dec 23).
Acadia Healthcare Company SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 9 | 4 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 9 | 8 | 7 | 6 | 5 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $45.55M | $45.54M | $43.80M | $52.55M | $51.98M | $51.71M | $51.63M | $48.16M | $6.13M | $45.26M | $44.32M | $41.03M | $-88.25M | $82.54M | $79.44M | $524.44M | $513.54M | $510.89M |
| Avg Forecast | $74.83M | $76.54M | $74.48M | $71.73M | $68.53M | $70.26M | $68.14M | $65.33M | $61.92M | $64.46M | $61.81M | $55.54M | $57.23M | $57.13M | $56.00M | $50.49M | $6.85M | $51.72M | $51.19M | $45.90M | $46.25M | $46.52M | $44.11M | $39.21M | $65.05M | $62.95M | $60.03M | $469.24M | $61.38M | $62.18M |
| High Forecast | $76.64M | $78.40M | $76.28M | $73.47M | $70.18M | $71.96M | $69.79M | $66.11M | $63.94M | $64.47M | $61.86M | $66.65M | $57.65M | $57.13M | $57.36M | $60.59M | $8.22M | $51.72M | $51.19M | $55.08M | $46.25M | $46.52M | $44.11M | $47.05M | $65.05M | $62.95M | $60.03M | $563.08M | $61.38M | $62.18M |
| Low Forecast | $73.58M | $75.27M | $73.23M | $70.53M | $67.38M | $69.09M | $67.00M | $64.71M | $60.84M | $64.44M | $61.75M | $44.43M | $56.91M | $57.13M | $55.07M | $40.39M | $5.48M | $51.72M | $51.19M | $36.72M | $46.25M | $46.52M | $44.11M | $31.36M | $65.05M | $62.95M | $60.03M | $375.39M | $61.38M | $62.18M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.80% | 0.80% | 0.78% | 1.04% | 7.59% | 1.00% | 1.01% | 1.05% | 0.13% | 0.97% | 1.00% | 1.05% | -1.36% | 1.31% | 1.32% | 1.12% | 8.37% | 8.22% |
Acadia Healthcare Company's average Quarter SG&A projection for Mar 24 is $55.54M, based on 4 Wall Street analysts, with a range of $44.43M to $66.65M. The forecast indicates a 21.95% rise compared to ACHC last annual SG&A of $45.55M (Dec 23).
Acadia Healthcare Company EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 9 | 4 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 9 | 8 | 7 | 6 | 5 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.63 | $-2.39 | $0.79 | $0.73 | $0.68 | $0.79 | $0.89 | $0.68 | $0.80 | $0.74 | $0.50 | $0.11 | $-8.91 | $0.42 | $0.47 | $0.38 | $-0.13 | $0.49 |
| Avg Forecast | $1.01 | $1.12 | $1.09 | $0.92 | $0.89 | $1.01 | $0.97 | $0.82 | $0.75 | $0.90 | $0.88 | $0.80 | $0.79 | $0.89 | $0.86 | $0.71 | $0.75 | $0.79 | $0.78 | $0.64 | $0.68 | $0.72 | $0.63 | $0.44 | $0.64 | $0.54 | $0.39 | $0.38 | $0.49 | $0.55 |
| High Forecast | $1.04 | $1.15 | $1.12 | $0.95 | $0.92 | $1.04 | $1.00 | $0.91 | $0.88 | $0.90 | $0.88 | $0.80 | $0.82 | $0.89 | $0.88 | $0.73 | $0.77 | $0.79 | $0.78 | $0.64 | $0.68 | $0.72 | $0.63 | $0.44 | $0.64 | $0.54 | $0.39 | $0.38 | $0.49 | $0.55 |
| Low Forecast | $0.99 | $1.09 | $1.06 | $0.90 | $0.87 | $0.99 | $0.95 | $0.77 | $0.70 | $0.90 | $0.87 | $0.80 | $0.76 | $0.89 | $0.84 | $0.69 | $0.73 | $0.79 | $0.78 | $0.64 | $0.68 | $0.72 | $0.63 | $0.44 | $0.64 | $0.54 | $0.39 | $0.38 | $0.49 | $0.55 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.79% | -2.68% | 0.92% | 1.03% | 0.91% | 1.00% | 1.14% | 1.07% | 1.17% | 1.02% | 0.80% | 0.25% | -14.02% | 0.78% | 1.21% | 1.00% | -0.26% | 0.89% |
According to 4 Wall Street analysts, Acadia Healthcare Company's projected average Quarter EPS for Mar 24 is $0.80, with a low estimate of $0.80 and a high estimate of $0.80. This represents a 26.50% increase compared to ACHC previous annual EPS of $0.63 (Dec 23).
Acadia Healthcare Company Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ACHC | Acadia Healthcare Company | $37.09 | $82.33 | 121.97% | Buy |
| AMED | Amedisys | $90.00 | $143.38 | 59.31% | Hold |
| INNV | InnovAge | $4.78 | $6.80 | 42.26% | Hold |
| EHAB | Enhabit | $7.27 | $10.25 | 40.99% | Hold |
| OPCH | Option Care Health | $21.82 | $29.50 | 35.20% | Buy |
| ADUS | Addus HomeCare | $120.20 | $132.80 | 10.48% | Buy |
| PNTG | Pennant Group | $31.81 | $34.67 | 8.99% | Buy |
| SEM | Select Medical | $37.01 | $40.00 | 8.08% | Buy |
| ENSG | Ensign Group | $144.56 | $148.20 | 2.52% | Buy |
| EHC | Encompass Health | $99.10 | $97.00 | -2.12% | Buy |
| HCA | HCA Healthcare | $335.11 | $310.75 | -7.27% | Buy |
| THC | Tenet Healthcare | $153.35 | $128.60 | -16.14% | Buy |
| DVA | DaVita | $156.98 | $125.50 | -20.05% | Hold |